Literature DB >> 10438856

Murine gammaherpesvirus 68 encodes a functional regulator of complement activation.

S B Kapadia1, H Molina, V van Berkel, S H Speck, H W Virgin.   

Abstract

Sequence analysis of the murine gammaherpesvirus 68 (gammaHV68) genome revealed an open reading frame (gene 4) which is homologous to a family of proteins known as the regulators of complement activation (RCA proteins) (H. W. Virgin, P. Latreille, P. Wamsley, K. Hallsworth, K. E. Weck, A. J. Dal Canto, and S. H. Speck, J. Virol. 71:5894-5904, 1997). The predicted gene 4 product has homology to other virally encoded RCA homologs, as well as to the complement-regulatory proteins decay-accelerating factor and membrane cofactor protein. Analyses by Northern blotting and rapid amplification of cDNA ends revealed that gene 4 is transcribed as a 5.2-kb bicistronic transcript of the late kinetic class. Three gammaHV68 RCA protein isoforms (60 to 65 kDa, 50 to 55 kDa, and 40 to 45 kDa) were detected by Western blotting of infected murine NIH 3T12 fibroblast cells. A soluble 40- to 45-kDa isoform was detected in the supernatants of virally infected cells. Flow cytometric analysis revealed that the gammaHV68 RCA protein was expressed on the surfaces of infected cells. Supernatants from virally infected cells contained an activity that inhibited murine complement activation as measured by inhibition of C3 deposition on activated zymosan particles. Recombinant gammaHV68 RCA protein, containing the four conserved short consensus repeats, inhibited murine C3 deposition on zymosan via both classical and alternative pathways and inhibited deposition of human C3 on activated zymosan particles. Expression of this inhibitor of complement activation, both at the cell surface and in the fluid phase, may be important for gammaHV68 pathogenesis via the inhibition of innate and adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438856      PMCID: PMC104293     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

1.  Analysis of murine gammaherpesvirus-68 transcription during lytic and latent infection.

Authors:  J P Simas; D Swann; R Bowden; S Efstathiou
Journal:  J Gen Virol       Date:  1999-01       Impact factor: 3.891

2.  Pathogenesis of acute and persistent murine herpesvirus infection in mice.

Authors:  J Rajcáni; D Blaskovic; J Svobodová; F Ciampor; D Hucková; D Staneková
Journal:  Acta Virol       Date:  1985-01       Impact factor: 1.162

3.  Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity.

Authors:  E M Adams; M C Brown; M Nunge; M Krych; J P Atkinson
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

4.  Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.

Authors:  H M Friedman; L Wang; N O Fishman; J D Lambris; R J Eisenberg; G H Cohen; J Lubinski
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

5.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

6.  Primary structure of the herpesvirus saimiri genome.

Authors:  J C Albrecht; J Nicholas; D Biller; K R Cameron; B Biesinger; C Newman; S Wittmann; M A Craxton; H Coleman; B Fleckenstein
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

7.  The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.

Authors:  M Engelstad; G L Smith
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

8.  Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity.

Authors:  T A McNearney; C Odell; V M Holers; P G Spear; J P Atkinson
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

9.  Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.

Authors:  Y U Kim; T Kinoshita; H Molina; D Hourcade; T Seya; L M Wagner; V M Holers
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

10.  Lung epithelial cells are a major site of murine gammaherpesvirus persistence.

Authors:  J P Stewart; E J Usherwood; A Ross; H Dyson; T Nash
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

View more
  45 in total

1.  Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis.

Authors:  Victor van Berkel; Beth Levine; Sharookh B Kapadia; James E Goldman; Samuel H Speck; Herbert W Virgin
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

2.  Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein.

Authors:  O Brad Spiller; Mairi Robinson; Elizabeth O'Donnell; Steven Milligan; B Paul Morgan; Andrew J Davison; David J Blackbourn
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice.

Authors:  Shivaprakash Gangappa; Sharookh B Kapadia; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Gammaherpesvirus gene expression and DNA synthesis are facilitated by viral protein kinase and histone variant H2AX.

Authors:  Bryan C Mounce; Fei Chin Tsan; Lindsay Droit; Sarah Kohler; Justin M Reitsma; Lisa A Cirillo; Vera L Tarakanova
Journal:  Virology       Date:  2011-09-22       Impact factor: 3.616

Review 5.  Immune evasion by Kaposi's sarcoma-associated herpesvirus.

Authors:  Hye-Ra Lee; Stacy Lee; Preet M Chaudhary; Parkash Gill; Jae U Jung
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

6.  IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site.

Authors:  A J Dal Canto; P E Swanson; A K O'Guin; S H Speck; H W Virgin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 7.  Immune regulation of viral infection and vice versa.

Authors:  Herbert W Virgin
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

8.  Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compared to immunization with gD alone.

Authors:  Sita Awasthi; John M Lubinski; Carolyn E Shaw; Shana M Barrett; Michael Cai; Fushan Wang; Michael Betts; Susan Kingsley; Daniel J Distefano; John W Balliet; Jessica A Flynn; Danilo R Casimiro; Janine T Bryan; Harvey M Friedman
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

9.  Glycoprotein L sets the neutralization profile of murid herpesvirus 4.

Authors:  Laurent Gillet; Marta Alenquer; Daniel L Glauser; Susanna Colaco; Janet S May; Philip G Stevenson
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

10.  Antibody limits in vivo murid herpesvirus-4 replication by IgG Fc receptor-dependent functions.

Authors:  Debbie E Wright; Susanna Colaco; Camilo Colaco; Philip G Stevenson
Journal:  J Gen Virol       Date:  2009-07-22       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.